FSD Pharma Inc Class B

Company Profile

FSD Pharma Inc Class B had its IPO on 2018-06-08 under the ticker symbol HUGE.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. FSD Pharma Inc Class B has a staff strength of 17 employees.

Stock update

Shares of FSD Pharma Inc Class B opened at $1.3 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $1.26 - $1.3, and closed at $1.29.

This is a -0.08% slip from the previous day's closing price.

A total volume of 82,676 shares were traded at the close of the day’s session.

In the last one week, shares of FSD Pharma Inc Class B have increased by +0.7%.

FSD Pharma Inc Class B's Key Ratios

FSD Pharma Inc Class B has a market cap of $50.56 million, indicating a price to book ratio of 0.875 and a price to sales ratio of 91.8563.

In the last 12-months FSD Pharma Inc Class B’s revenue was $0 with a gross profit of $-3331945 and an EBITDA of $-24982220. The EBITDA ratio measures FSD Pharma Inc Class B's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, FSD Pharma Inc Class B’s operating margin was 0% while its return on assets stood at -50.64% with a return of equity of -98.83%.

In Q2, FSD Pharma Inc Class B’s quarterly earnings growth was a positive 0% while revenue growth was a negative 7.4%.

FSD Pharma Inc Class B’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

0

Its diluted EPS in the last 12-months stands at $-0.74 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into FSD Pharma Inc Class B’s profitability.

FSD Pharma Inc Class B stock is trading at a EV to sales ratio of 98.5599 and a EV to EBITDA ratio of -0.3684. Its price to sales ratio in the trailing 12-months stood at 91.8563.

FSD Pharma Inc Class B stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$21.41 million

Total Liabilities

$5.85 million

Operating Cash Flow

$0

Capital Expenditure

$0

Dividend Payout Ratio

0%

FSD Pharma Inc Class B ended 2024 with $21.41 million in total assets and $0 in total liabilities. Its intangible assets were valued at $21.41 million while shareholder equity stood at $15.55 million.

FSD Pharma Inc Class B ended 2024 with $0 in deferred long-term liabilities, $5.85 million in other current liabilities, 137458521.00 in common stock, $-155404547.00 in retained earnings and $0 in goodwill. Its cash balance stood at $5.67 million and cash and short-term investments were $5.68 million. The company’s total short-term debt was $407,751 while long-term debt stood at $0.

FSD Pharma Inc Class B’s total current assets stands at $9.11 million while long-term investments were $550283.00 and short-term investments were $11050.00. Its net receivables were $2.92 million compared to accounts payable of $3.91 million and inventory worth $0.

In 2024, FSD Pharma Inc Class B's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, FSD Pharma Inc Class B paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$1.29

52-Week High

$2.1

52-Week Low

$0.618

Analyst Target Price

$

FSD Pharma Inc Class B stock is currently trading at $1.29 per share. It touched a 52-week high of $2.1 and a 52-week low of $2.1. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $1.24 and 200-day moving average was $1.23 The short ratio stood at 1.32 indicating a short percent outstanding of 0%.

Around 2334.4% of the company’s stock are held by insiders while 268.4% are held by institutions.